FDA warns of eye infection from repackaged Avastin

08/30/2011 | New York Times (tiered subscription model), The

In a public alert, the FDA reported at least 12 cases of serious eye infection in Florida patients treated with Genentech's injectable drug Avastin that was repackaged at a pharmacy. Meanwhile, a Tennessee newspaper reported that four patients were given shots with bacterial contamination. Avastin is approved to treat cancer but is used off-label to treat wet age-related macular degeneration.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ